AU2198100A - Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma - Google Patents

Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Info

Publication number
AU2198100A
AU2198100A AU21981/00A AU2198100A AU2198100A AU 2198100 A AU2198100 A AU 2198100A AU 21981/00 A AU21981/00 A AU 21981/00A AU 2198100 A AU2198100 A AU 2198100A AU 2198100 A AU2198100 A AU 2198100A
Authority
AU
Australia
Prior art keywords
sarcosystis
neospora
toxoplasma
treating diseases
diseases due
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21981/00A
Inventor
Thomas J. Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of AU2198100A publication Critical patent/AU2198100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU21981/00A 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma Abandoned AU2198100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21871298A 1998-12-22 1998-12-22
US09218712 1998-12-22
PCT/US1999/030284 WO2000037084A1 (en) 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
AU2198100A true AU2198100A (en) 2000-07-12

Family

ID=22816194

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21981/00A Abandoned AU2198100A (en) 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Country Status (12)

Country Link
EP (1) EP1140101A1 (en)
JP (1) JP2002532552A (en)
KR (1) KR20010080571A (en)
CN (1) CN1331595A (en)
AU (1) AU2198100A (en)
BR (1) BR9916417A (en)
CA (1) CA2356181A1 (en)
HK (1) HK1043065A1 (en)
HU (1) HUP0104716A3 (en)
NZ (1) NZ512476A (en)
WO (1) WO2000037084A1 (en)
ZA (1) ZA200103919B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01003542A (en) 1998-10-08 2002-09-18 New Ace Res Company Novel compositions and methods for prevention and treatment of protozoal disease.
DE19958388A1 (en) * 1999-12-03 2001-06-07 Bayer Ag Triazinone compounds for the treatment of infestations with parasitic protozoa-related diseases
DE10040110A1 (en) * 2000-08-17 2002-02-28 Bayer Ag Use of triazinetrione sulfoxides to combat coccidioses
DE10040174A1 (en) * 2000-08-17 2002-02-28 Bayer Ag Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives
DE102007025908A1 (en) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulations containing triazinones and iron
DE102009012423A1 (en) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Preparation based on oil
CN102973497A (en) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 Toltrazuril solution and preparation method thereof
BR112020017341A2 (en) 2018-02-26 2020-12-15 AlzeCure Pharma AB TRIAZINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO NEUROTROFINS
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis

Also Published As

Publication number Publication date
HUP0104716A3 (en) 2003-10-28
NZ512476A (en) 2003-08-29
WO2000037084A1 (en) 2000-06-29
ZA200103919B (en) 2002-05-15
BR9916417A (en) 2001-11-06
EP1140101A1 (en) 2001-10-10
HUP0104716A2 (en) 2002-04-29
KR20010080571A (en) 2001-08-22
CN1331595A (en) 2002-01-16
HK1043065A1 (en) 2002-09-06
JP2002532552A (en) 2002-10-02
CA2356181A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
GB9828640D0 (en) Novel method and compounds
AU6111699A (en) Novel method and compounds
GB9818732D0 (en) Collection of compounds
AU4568799A (en) Biosensor
EP1102535A4 (en) Compounds and methods
GB0004234D0 (en) Early entry
GB0010544D0 (en) Early entry
AU1772399A (en) Well treatment
HUP0104710A3 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing the same
AUPP433398A0 (en) Compounds and processes
AU2198100A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
HUP0104595A3 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
TW355980U (en) Structure for paper-produced straw
GB9909183D0 (en) Early entry
GB9902662D0 (en) Early entry
GB0006163D0 (en) No title early entry
PL335668A1 (en) Shield
GB2360051B (en) Structural trusses
AU4165699A (en) Composition for treating cartilage disease
AU5314999A (en) Modified oligonucleotides
AU6488299A (en) Bio neutralizer-transformer
AU2226599A (en) Methods to identify myelostimulants
AUPP590998A0 (en) Improvements relating to trusses
GB9919461D0 (en) Early entry
AU1141300A (en) Improved reactor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase